Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Jun 27, 2021; 13(6): 686-698
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Table 3 Multivariate model on mortality

Response
Beta estimate
Standard error
P value for beta
Odds ratio (95%CI)
Age0.0240.003< 0.00011.024 (1.019, 1.029)
Acute respiratory FailureYes (reference = No)1.6520.109< 0.00015.219 (4.211, 6.468)
Intestinal infarct/acute vascular insufficiencyYes (reference = No)1.4220.201< 0.00014.143 (2.795, 6.142)
Acute liver failureYes (reference = No)1.2860.119< 0.00013.617 (2.864, 4.567)
Hepatorenal syndromeYes (reference = No)1.1230.147< 0.00013.072 (2.302, 4.101)
CancerYes (reference = No)0.8820.098< 0.00012.415 (1.993, 2.927)
Acute kidney injuryYes (reference = No)0.8030.092< 0.00012.232 (1.862, 2.675)
Sepsis/severe sepsis/septic shockYes (reference = No)0.6350.122< 0.00011.886 (1.484, 2.398)
Hepatic encephalopathyYes (reference = No)0.2800.1170.0201.323 (1.052, 1.662)
Elixhauser Comorbidity Score excluding liver disease0.0260.004< 0.00011.027 (1.019, 1.034)